Patents by Inventor NEURENDO PHARMA, LLC

NEURENDO PHARMA, LLC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF RESTORING THE INCRETIN EFFECT
    Publication number: 20130224176
    Abstract: The present invention relates to methods of treating metabolic syndrome, Type 2 diabetes mellitus, atherogenic dyslipidemia and/or obesity. The present invention also relates to methods of restoring the incretin effect, to restoring physiologic control of glucagon levels, to restoring first-phase insulin secretion, and to restoring the physiologic glucose-dependent insulin secretion. The methods of the present invention comprise administration of a selective ?-receptor antagonist, such as guanidinylated naltrindole (GNTI), or pharmaceutically acceptable derivatives thereof to a subject in need thereof.
    Type: Application
    Filed: April 10, 2013
    Publication date: August 29, 2013
    Applicant: NEURENDO PHARMA, LLC
    Inventor: NEURENDO PHARMA, LLC
  • METHOD OF RESTORING THE INCRETIN EFFECT
    Publication number: 20130172380
    Abstract: The present invention relates to methods of treating metabolic syndrome, Type 2 diabetes mellitus, atherogenic dyslipidemia and/or obesity. The present invention also relates to methods of restoring the incretin effect, to restoring physiologic control of glucagon levels, to restoring first-phase insulin secretion, and to restoring the physiologic glucose-dependent insulin secretion. The methods of the present invention comprise administration of a selective ?-receptor antagonist, such as guanidinylated naltrindole (GNTI), or pharmaceutically acceptable derivatives thereof to a subject in need thereof.
    Type: Application
    Filed: February 22, 2013
    Publication date: July 4, 2013
    Applicant: NEURENDO PHARMA, LLC
    Inventor: NEURENDO PHARMA, LLC